# Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets

Study · id `cardio:ct-nct05627375` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05627375](<https://clinicaltrials.gov/study/NCT05627375>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05627375

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1400 participants.

## Technical summary

Registry record NCT05627375. Randomized; no masking; primary purpose treatment. Start 2023-08-16 (actual); primary completion 2027-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 1400 participants (planned count; ClinicalTrials.gov record NCT05627375, source copy `cardio:ctgov-nct05627375-2026-05-08`, retrieved 2026-10-31)
- Started: 2023-08-16 (actual) (ClinicalTrials.gov record NCT05627375, source copy `cardio:ctgov-nct05627375-2026-05-08`, retrieved 2026-10-31)
- Primary completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT05627375, source copy `cardio:ctgov-nct05627375-2026-05-08`, retrieved 2026-10-31)
- Completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT05627375, source copy `cardio:ctgov-nct05627375-2026-05-08`, retrieved 2026-10-31)
- Countries: France (ClinicalTrials.gov record NCT05627375, source copy `cardio:ctgov-nct05627375-2026-05-08`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05627375-2026-05-08`, retrieved 2026-10-31)

## The registry's words

- Brief title: Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets
- Acronym: BAT-VTE
- Condition: Venous Thromboembolic Disease
- Intervention (Drug): Full-dose anticoagulant therapy (AC)
- Intervention (Drug): Antiplatelet therapy (AP)
- Lead sponsor: Centre Hospitalier Universitaire de Saint Etienne
- Lead sponsor class: OTHER
- Collaborator: Ministry of Health, France
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Deep vein thrombosis (`cardio:deep-vein-thrombosis`)
- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)
- Registry lists this organization as the lead sponsor: Centre Hospitalier Universitaire de Saint Etienne (`cardio:org-centre-hospitalier-universitaire-de-saint-etienne`)
- Registry lists this organization as a collaborator: Ministry of Health, France (`cardio:org-ministry-of-health-france`)

## Provenance

Content hash: 2c93ed2a8e39b500ca04aa30e32beb7922c89cecdb9e0b0959451b51f9a701a8
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
